Characterization of a human bispecific antibody against CD20/CD55 for the treatment of burkitt lymphoma

被引：0
|
作者：
Macor, Paolo [1 ]
Mezzaroba, Nelly [1 ]
De Maso, Luca [1 ]
Garrovo, Chiara [2 ]
Biffi, Stefania [2 ]
Sblattero, Daniele [3 ]
Marzari, Roberto [1 ]
Tedesco, Francesco [1 ]
机构：
[1] Univ Trieste, Dept Life Sci, Trieste, Italy
[2] CBM, Opt Imaging Lab, Trieste, Italy
[3] Univ Piemonte Orientale, Dept Med Sci, Novara, Italy
来源：
IMMUNOBIOLOGY | 2012年 / 217卷 / 11期
关键词：
D O I：
10.1016/j.imbio.2012.08.060
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
59
引用
收藏
页码：1149 / 1150
页数：2
相关论文
共 50 条
  • [41] Structural insight into CD20/CD3-bispecific antibodies by molecular modeling
    Sun, Ze-Yu
    Liang, Tianjian
    Zhang, Yiyang
    Hou, GanQian
    Chu, Xiaojie
    Hou, Jing-Zhou
    Li, Wei
    Xie, Xiang-Qun
    Feng, Zhiwei
    Computers in Biology and Medicine, 2025, 185
  • [42] Heterodimerization of CD74 and CD20 by two hexavalent, bispecific, anti-CD20/CD74 antibodies leads to potent cytotoxicity in mantle cell lymphoma
    Gupta, Pankaj
    Rossi, Edmund A.
    Goldenberg, David M.
    Chang, Chien-Hsing
    CANCER RESEARCH, 2011, 71
  • [43] Development of a Bispecific Nanobody Targeting CD20 on B-Cell Lymphoma Cells and CD3 on T Cells
    Liu, Yanlong
    Ao, Kexin
    Bao, Fuxiang
    Cheng, Yi
    Hao, Yanxia
    Zhang, Huimin
    Fu, Shan
    Xu, Jiaqi
    Wu, Qiyao
    VACCINES, 2022, 10 (08)
  • [44] Juxtaposing CD20 and CD74 with Novel Bispecific Antibodies Evokes Potent Cytotoxicity in Mantle Cell Lymphoma (MCL)
    Gupta, Pankaj
    Goldenberg, David M.
    Rossi, Edmund A.
    Cardillo, Thomas M.
    Byrd, John C.
    Muthusamy, Natarajan
    Furman, Richard R.
    Chang, Chien-Hsing
    BLOOD, 2011, 118 (21) : 275 - 275
  • [45] CD20 × CD3 bispecific antibodies for lymphoma therapy: latest updates from ASCO 2023 annual meeting
    Xinyuan Liu
    Juanjuan Zhao
    Xiangqian Guo
    Yongping Song
    Journal of Hematology & Oncology, 16
  • [46] Rituximab: A monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris
    El Tal, Abdul Kader
    Posner, Marshall R.
    Spigelman, Zachary
    Ahmed, A. Razzaque
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (03) : 449 - 459
  • [47] Treatment of vitiligo with a chimeric monoclonal antibody to CD20: a pilot study
    Ruiz-Argueelles, A.
    Garcia-Carrasco, M.
    Jimenez-Brito, G.
    Sanchez-Sosa, S.
    Perez-Romano, B.
    Garces-Eisele, J.
    Camacho-Alarcon, C.
    Reyes-Nunez, V.
    Sandoval-Cruz, M.
    Mendoza-Pinto, C.
    Lopez-Colombo, A.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 174 (02): : 229 - 236
  • [48] Expression and function of human CD59 and human CD55 in transgenic mice
    Somerville, C
    vanDenderen, B
    Adam, B
    Aminian, A
    Allison, J
    Pearse, M
    dApice, A
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (06) : 3565 - 3566
  • [49] Expression of complement inhibitors CD46, CD55 and CD59 and response to rituximab in patients with CD20+ non hodgkins lymphoma
    Dzietczenia, J.
    Wrobel, T.
    Mazur, G.
    Biedron, M.
    Jazwiec, B.
    Kuliczkowski, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 533 - 533
  • [50] ANALYSIS OF THE HUMAN CD20 PROMOTER
    THEVENIN, C
    KEHRL, JH
    CLINICAL RESEARCH, 1993, 41 (02): : A169 - A169
12345